Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) (PAR-21-233)

Sponsor: National Institutes of Health

Due Date: August 10, 2021; February 9, 2022; August 9, 2022; February 9, 2023; August 9, 2023; February 9, 2024

NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed) (PAR-21-234)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 12, 2021.

NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed) (RFA-NS-21-012)

Sponsor: National Institutes of Health

Award: The NIH Blueprint and BRAIN Initiative intend to commit up to $1.1 million per fiscal year to fund approximately 25 awards per year. However, the total amount awarded and the number of awards made will depend upon the number, quality, and cost of the applications received. Future year amounts will depend on annual appropriations.

Due Date: December 15, 2021; April 15, 2022; December 15, 2022; April 14, 2023; December 15, 2023

Notice of Special Interest (NOSI): Availability of Funds to defray Childcare Costs for NCI, NIA, NIDCR, NIDDK, and NIH Blueprint Predoctoral to Postdoctoral Fellow Transition Programs F99 Awardees (NO

Sponsor: National Institutes of Health

Notice of Special Interest (NOSI): Administrative Supplements to Promote Diversity for NINDS Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) Awardees (NOT-NS-21-047)

Sponsor: National Institute of Neurological Disorders and Stroke

Notice of Pre-Application Webinar for Companion Announcements PAR-21-207 and RFA-AG-22-016 Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (

Sponsor: National Institute on Aging

Notice of Intent to Publish the Reissuance of PAR-18-420, NINDS Exploratory Clinical Trials (U01 - Clinical Trial Required) (NOT-NS-21-054)

Sponsor: National Institute of Neurological Disorders and Stroke

NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed) (PAR-21-152)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 12, 2021.

NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Clinical Trial Required) (PAR-21-153)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 12, 2021.

NINDS Program Project Grant (P01 Clinical Trial Optional) (PAR-21-181)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple dates, see announcement.

Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Optional) (

Sponsor: National Institute on Aging

Award: NIA intends to commit $2,250,000 in both FY 2022 and FY 2023 to fund four to six awards.

Due Date: Multiple dates, see announcement.

Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R61/R33 Clinical Trial Require

Sponsor: National Institute on Aging

Award: NIA intends to commit $3 million in FY 2022 to fund six to eight awards.

Due Date: September 15, 2021

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access and Manipulation to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) (RFA-MH-21-1

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $2 million per year to fund two to four awards.

Due Date: Multiple dates, see announcement.

Advancing Research on Care and Outcome Measurement (ARCOM)

Sponsor: Alzheimer's Association

Award: $250,000

Due Date: May 5, 2021, 5 p.m. ET

3-year NIH INSPIRE Postdoctoral Fellowship at Rutgers University, on the Cognitive Neuroscience of Aging, Brain Health, and Alzheimer's Prevention

Due Date: May 1, 2021